Recent Advances in Noninvasive Brain Stimulation for Child and Adolescent Psychiatric Disorders
You’re invited to join the Clinical TMS Society for this installment of our Grand Round Webinar Series: Recent Advances in Noninvasive Brain Stimulation for Child and Adolescent Psychiatric Disorders
- Demonstrate a working knowledge of noninvasive brain stimulation modalities and recent research with child and adolescent patients.
- Explain the different among single-pulses, paired-pulse, low frequency, high frequency, and theta burst stimulation in transcranial magnetic stimulation clinical work and research.
- Describe recent research focused on accelerated transcranial magnetic stimulation protocols.
Date of Release: January 8, 2021
Date of Expiration: January 7, 2023
Cost: Members: $25 | Non-members $50 | Student Members FREE
SPEAKER: Paul Croarkin, DO
Dr. Croarkin’s research program focuses on adapting and innovating brain stimulation interventions in children and adolescents. This includes biomarker work to optimize diagnostic practices and the delivery of brain based interventions such as transcranial magnetic stimulation. A central theme focuses on the role of gamma-aminobutyric acid (GABA) and glutamate neurotransmitter systems in early-onset mood disorders with the goal of informing safer and more effective biologic treatments. Dr. Croarkin is a professor of psychiatry in the Mayo Clinic College of Medicine.
**As a reminder, you must be logged into the Clinical TMS dashboard to view the recording. If you are having trouble accessing the webinar, please refer to the appropriate access instructions below.
Acknowledgement of Financial and/or In-Kind Commercial Support
No financial or in-kind commercial support was received for this educational activity.
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement – Amedco LLC designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Questions? Email Certificate@AmedcoEmail.com